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1. Introduction
The temporomandibular joint (TMJ) is a unique joint; despite
advanced degenerative changes being present in the joint, it allows
a range of movement of the associated structures to achieve a
modified function [1]. TMJ Internal Derangement (ID) is a common
form of temporomandibular disorders (TMDs), almost 80% of adult
symptomatic patients with TMD have some form of ID [2].
Data from related literature has suggested that arthrocentesis
may be of some benefit to manage symptoms of TMDs. Such a
technique was first introduced for the management of sudden
onset of closed lock [3]. Arthrocentesis is the single most important
non-invasive procedure in musculoskeletal medicine. Therapeutic
arthrocentesis is the basic underlying procedure for intra-articular
treatment, including; needle lavage and intra-articular injection of
therapeutic substances [4].
One of these therapeutic substances is the hyaluronic acid (HA),
Exogenous (HA) can stimulate the synthesis of endogenous (HA)e
forming synoviocytes of osteoarthritic joints, so reducing joint
friction coefficient and decreasing risk of damage [5].
There is scientific and clinical evidence for the analgesic and
anti-inflammatory properties of Intra-articular (IA) administered
opioids; both in acute and chronic joint pain [6]. Intra-articular
injection of opioids has been reported in various studies (Likar
et al. [7] 1997; Gupta et al. [8] 2001; Kalso et al. [9] 2002), but ac-
cording to current study, no survey has been made for the evalu-
ation of fentanyl in TMJ intra-articular injection.
Opioid agonists have powerful anti-inflammatory properties
and they exert their action in the periphery via opioids receptors
[10].
Fentanyl is a synthetic potent mu opioid receptor agonist char-
acterized by both high potency and high lipid solubility; it is
approximately 80 times more potent than morphine and binds
strongly to plasma proteins [11,12].
1.1. Review of literature
Temporomandibular joint internal derangement (TMJ ID) is one
of the most common forms of TMDs, defined as “an abnormal po-
sitional and functional relationship between the articular disk, the
mandibular condyle and the articular surfaces of the temporal
bone” [13,14].
Pain and limitation of mandibular movements were the main
complaint of patients seeking treatment as concluded by Vascon-
celos Filho et al. [15] and Wilkes [16].
It is believed that physical action of lysis and lavage in the su-
perior joint space, rather than disc repositioning, is responsible for
the success of arthroscopic surgery [17,18]. Arthrocentesis for the
TMJ was introduced by Nitzan et al. [19] in 1991 as a minimally
invasive safe procedure carries a very low risk, few complications. It
appears to have filled the clinical void between failed non-surgical
treatment and open arthrotomy [20].
It involves inserting needle inside and washing out the joint
with sterile fluids as saline, lactated Ringer's solution, then fluid in
the joint cavity is aspirated with another needle [21,22] and if
needed, a therapeutic substance is then injected [23]. This treat-
ment rationale was based on two treatment modalities namely
pumping manipulation procedure and the arthroscopic lysis and
lavage. Irrigating the superior joint space will result in the creation
of the hydraulic pressure and distension, which will release the
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displaced disc and thereby re-establish normal maximal mouth
opening [21,22,24].
Many reports have pointed out the importance of intra-articular
injections of therapeutic substances such as viscoelastic solution,
steroids, anti-inflammatory drugs, local anesthetics and opioid
drugs into the superior joint space [21,25e27]].
Based on the hypothesis that a normal disc-condyle- glenoid
fossa relationship depends on a low friction coefficient; hyaluronic
acid is the first choice for TMJ infiltrations because it seems to be
important for joint stabilization and joint surface nutrition, so its
use might be useful to restore the lubrication system [28,29]. HA
plays an important role in maintaining intra-articular homeostasis:
it favors the elasticity and viscosity of the synovial fluid, providing a
cushion against any shocks; it has a lubricating, anti-inflammatory
and pain-relieving action and enables the tissue repair processes
to be activated in the cartilage with a normalizing action on the
synthesis of endogenous acid by the synovial cells [30]. The prin-
ciple of viscosupplementationwas pioneered in 1982 by Balazs et al.
[31]. Viscosupplementation using HA is a procedure that involves
injecting HA into a joint to replace the lost HA and potentially
stimulate the production of endogenous HA within the joint [32].
It was concluded also that intra-articular injection of tramadol
opioid is effective in management of clinical symptoms associated
with internal derangements of the TMJ [33]. Opioids exert their
pharmacological actions by binding to specific cellular receptors.
Receptors are primarily responsible for the observed pharmaco-
logical effects. Binding (or blockade) to these receptors alters many
clinically important physiological functions, these receptors are
widespread throughout the central and peripheral nervous systems
[34e36]. These peripheral opioid receptors play a critical role in
modulating pain and inflammation. Russell et al. [37] demonstrated
that the peripheral analgesic effect of opioids is mediated by acti-
vation of opioid receptors in the peripheral nervous system (PNS)
and other cells, especially in presence of inflammation. Opioids
injected locally into joints produce potent and receptor-specific
analgesic effects that are mediated by peripheral opioid receptors,
occur in the absence of central analgesic activity, and are naloxone
reversible [38]. There is recent evidence of the existence of opioid
receptors in synovial tissue [39,40].
Fentanyl, act on the mu receptors, and to a lesser degree on
kappa receptors.
In the presence of tissue inflammation; number of nociceptor
nerve endings increase and perineural barrier is disrupted, facili-
tating access of opioid agonists to their receptors, resulting in
enhanced peripheral analgesic efficacy of opioids [41,42]. Inflam-
mation as well, increases the permeability of the perineurium,
thereby exposing the receptors at the sensory nerve terminals to
endogenous and exogenous opioids [42]. Mu-opioid agonists, have
therapeutic anti-inflammatory activity by reducing expression of
the adhesion molecule, inhibiting cell trafficking, reducing release
and expression of tumor necrosis factor (TNF), and altering
expression of mRNA and levels of proteins in joint tissue. The
mechanism underlying the anti-inflammatory effect of MOR is
suggested to be mediated through regulation of cytokine produc-
tion and T cell proliferation [10].
1.2. Aim of the study
The aim of the current study was to assess intra-articular in-
jection of Fentanyl following arthrocentesis for the management of
internal derangement of the tempromandibular joint.
2. Materials and methods
This study was carried out on 40 tempromandibular joints of
adult patients suffering from internal derangement. The selected
patients were 20 females with age ranging from 20 to 34 years old
withmean age about 27 years with chief complain of limitedmouth
opening, TMJ pain and clicking sounds in the TMJ.
Patients with history of degenerative joint disease or those who
had performed previous surgical treatment were excluded from
this study; also patients with limited mouth opening caused by
only muscle pain or muscle spasm were excluded.
All patients were subjected to:
1. Clinical examination including;
a. Pain intensity recorded on visual analogue scale (VAS) with
endpoints 0 score for no pain and 10 score for the worst pain
experienced,
b. Maximal mouth opening measured inter-incisally with digi-
tal calipers,
c. lateral mandibular excursions mean value of both right and
left measures weremeasured as mean value of both right and
left measures
d. Protrusive mandibular movements measured as the differ-
ence in overjet during rest and after protrusion of the
mandible.
These parameters were recorded also at the following intervals
postoperatively; immediate post-operative, one week, one month
and six months after the procedure.
2. Radiographic examination;
a. TMJ view (open and closed) was taken to detect osseous
degeneration
b. Magnetic resonance imaging for the affected joint had been
performed.
Based on these examinations and patient's history, a diagnosis
of TMJ internal derangement was made.
The treated joints were divided randomly into two groups;
1. Group I consisted of 20 joints where arthrocentesis was per-
formed for the affected joints followed by intra-articular injec-
tion of 1 ml fentanyl (Fig. 1e3).
2. Group II consisted of 20 joints where arthrocentesis was per-
formed for the affected joints followed by intra-articular injec-
tion of 1 ml commercially available sodium hyaluronate.
Fig. 1. Needles insertion at marked points.
H.-T.A.M. Fayed et al. / Future Dental Journal 2 (2016) 86e90 87




Descriptive statistics of pain throughout study periods in both
groups (Table 1).
Preoperatively and immediately post operative there was no
significant difference between Group I and II. In the following post
operative observation times1week, 1 month and 6 months; there
was a significant difference between both groups (p < 0.0001), with
higher values recorded in group II.
A bar chart showing mean values of pain score in both groups .
3.2. Interincisal opening
Descriptive statistics of interincisal opening throughout study
periods in both groups (Table 2).
Preoperatively and immediately post operative there was no
significant difference between Group I and II. In the following post
operative observation times 1week, 1 month and 6 months; there
was a significant difference between both groups, with higher
values recorded in group I (p < 0.0001).
A bar chart showing mean values of mouth opening (mm) in both groups .
3.3. Mandibular functions
Fig. 2. Tempromandibular joint arthrocentesis.
Fig. 3. Intra-articular fentanyl injection.
Table 1











Gp I Gp II Gp I Gp II Gp I Gp II Gp I Gp II Gp I Gp II
Mean 8.15 8.05 6.90 6.80 5.20 7.60 4.20 5.75 1.05 2.75
SD 0.94 0.82 1.55 1.19 1.10 0.94 0.69 1.16 0.68 0.71
P value 0.547ns 0.142ns <0.0001* <0.0001* <0.0001*
P.O. ¼ post operatively, Ns ¼ non-significant, *statistically significant at p < 0.05.
Table 2
Values of interincisal opening in both groups and significance of difference using t-test.
Group Pre-operative Immediate P$O 1 week P$O. 1 month P$O 6 months P$O
Gp I Gp II Gp I Gp II Gp I Gp II Gp I Gp II Gp I Gp II
Mean 19.90 17.20 17.40 16.70 24.00 15.95 31.60 22.45 33.75 30.40
SD 5.38 3.51 4.37 2.34 5.40 3.15 2.60 3.37 1.11 2.06
P value 0.678ns 0.5315ns <0.0001* <0.0001* <0.0001*
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A bar chart showing mean values of lateral & protrusive mandibular movements .
Preoperatively and immediately post operative there was no
significant difference between Group I and II. In the following post
operative observation times1week, 1 month and 6 months; there
was a greater mean value in group I.
The results of this study revealed that patients with either disc
displacement with reduction or without reduction benefited from
the arthrocentesis procedure followed by intra-articular injection
of fentanyl and also with intra-articular injection of sodium hya-
luronate. Both treatments were able to reduce pain levels, increase
maximal mouth openings, lateral and protrusive mandibular
movements. However, best results were recorded with arthro-
centesis followed by fentanyl intra-articular injection; at 1 week, 1
month and six months intervals; which was superior to arthro-
centesis followed by sodium hyaluronate intra-articular injection.
4. Discussion
There are very few studies related to TMJ intra-articular
administration of opioids. The current study revealed that fenta-
nyl significantly reduced pain intensity via intra-articular injection
through post-operative intervals in comparisonwith intra-articular
sodium hyaluronate injection after TMJ arthrocentesis.
Ever since pain pathways are understood by the clinicians,
importance has been given for utilizing the peripheral narcotic
receptors for management of pain Understanding, that opioids can
elicit analgesic effects by acting on peripheral opioid receptors, has
led to their experimentation in controlled clinical trials [43,44].
Peripheral opioid receptors may be activated only in the pres-
ence of tissue inflammation; also, opioid binding sites have been
identified in synovial tissues indicating that analgesia is locally
mediated. Opioid receptors are mostly located on the terminal end
of the nerves and they are activated by inflammation; in this situ-
ation afferent ends of the nerves and leukocytes are the target sites.
They have a longer analgesic effect in the intra-articular region
comparedwith systemic administration [45e47]. Fentanyl being fat
soluble opioid with less histamine release was proved in many
studies to be more effective in intra-articular analgesia than
morphine [43,48,49]; Histamine is a powerful activator of noci-
ceptors in the local tissues and induces substance-P release. His-
tamine and substance P produce vasodilatation and increased
vascular permeability, which lead to the release of bradykinin.
Substance P promotes additional release of histamine from mast
cells and serotonin from platelets [50,51]. Fentanyl being fat soluble
opioid with less histamine releasewas proved inmany studies to be
more effective in intra-articular analgesia than morphine
[43,48,49].
In accordance with current study results; Saryazdi et al. [52]
found that better postoperative analgesia and less pain score
were achieved by fentanyl and pethidine in comparison to dexa-
methasone but the results were not significantly different between
fentanyl group and pethidine. Further article by Mandal et al. [49]
concluded that although fentanyl is a short-acting narcotic drug,
its IA administration provided prolonged postoperative analgesia.
On the other hand; Uysalel et al. [53] concluded that a combi-
nation of intra-articular morphine and bupivacaine has a longer
analgesic duration than a combination of fentanyl and bupivacaine
for analgesia after arthroscopic surgery of the knee joint. Further-
more, on contrary to the present study; Manuar et al. [54] sug-
gested that intra-articular ropivacaine gives better postoperative
pain relief, with increased time of first analgesic request and
decreased need of total postoperative analgesia compared to fen-
tanyl and dexmedetomidine.
The current study revealed that sodium hyaluronate intra-
articular injection following TMJ arthrocentesis reduced pain in-
tensity with higher pain score through post-operative intervals
than fentanyl intra-articular injection that recorded superior re-
sults in decreasing pain intensity.
It is suggested that the analgesic effect of viscosupplementation
may occur by blocking receptors and endogenous algic substances
in the synovial tissues. A strictly mechanic mechanism by the
interruption of trauma caused by mechanic block of the disk or of
both adherence zones was also suggested [55], what could explain
the effects of therapy in medium and long term, because although
the injected HA is kept on the joint only for a few days the results
last for months [56,57].
The study results of Yakan et al. [58] were in agreement with the
present study as he estimated the efficacy of arthrocentesis and
hyaluronic acid injections for the treatment of temporomandibular
joint osteoarthritis.
Regarding mandibular functions, the present study results
showed higher mouth opening values, lateral excursion move-
ments and protrusive mandibular movement records in fentanyl
group through different postoperative intervals. In accordance to
current study, Hamed T [33]. compared arthrocentesis followed by
COX-2 inhibitor versus tramadol in management of internal de-
rangements of the tempromandibular joint. He concluded that
intra-articular injection of tramadol which is one of opioids is
effective in management of clinical symptoms as he found statis-
tically significant increase in both the maximum mouth opening
and the lateral excursion through all periods in COX-2 inhibitor and
tramadol groups, as well as significant decrease in mean VAS
however, tramadol showed a significant improvement in VSA,
maximum mouth opening and lateral excursion superior to those
of COX-2 inhibitor group.
5. Conclusion
Finally, it has been concluded that although fentanyl is a short
acting opioid drug; its intra-articular injection proved to be able to
achieve long term relief of pain as a symptom of TMJ internal
derangement, thus it can manage other symptoms as limitation of
mouth opening by allowing patients to use their mandibular
functions freely without pain. It is worthy to mention that sodium
hyaluronate was able to manage TMJ internal derangement
symptoms by decreasing pain intensity and increasing mouth
opening and lateral excursions; however, fentanyl was superior in
achieving significant improvement through post-operative in-
tervals with lower pain scores and higher mandibular functions
records.
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